Zai Lab (ZLAB) Interest & Investment Income (2020 - 2026)
Zai Lab (ZLAB) reported Interest & Investment Income of $6.4 million for Q1 2026, down 25.09% on a YoY basis from $8.6 million in Q1 2025, and down 11.12% sequentially from $7.3 million in Q4 2025.
Zai Lab (ZLAB) Interest & Investment Income (2020 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 7 years of Interest & Investment Income data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 25.09% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $30.9 million (down 14.32% YoY), and the FY2025 full-year result was $33.0 million, down 10.93% from the prior year.
- Interest & Investment Income retreated to $6.4 million in Q1 2026, from $7.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $10.3 million in Q4 2023 to a low of $188000.0 in Q1 2022.
- A 5-year average of $7.7 million and a median of $9.0 million in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 5342.55% in 2023 and decreased 25.09% in 2026, its largest moves.
- Tracing ZLAB's Interest & Investment Income over 5 years: stood at $9.3 million in 2022, then climbed by 10.24% to $10.3 million in 2023, then decreased by 11.8% to $9.1 million in 2024, then fell by 20.18% to $7.3 million in 2025, then decreased by 11.12% to $6.4 million in 2026.
- Business Quant data shows ZLAB's Interest & Investment Income at $6.4 million in Q1 2026, $7.3 million in Q4 2025, and $8.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | 6.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.45 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 8.35 Mn |
| Jun 30, 2025 | 8.84 Mn |
| Mar 31, 2025 | 8.61 Mn |
| Dec 31, 2024 | 9.09 Mn |
| Sep 30, 2024 | 9.03 Mn |
| Jun 30, 2024 | 9.33 Mn |
| Mar 31, 2024 | 9.66 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 10.09 Mn |
| Mar 31, 2023 | 10.23 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Sep 30, 2022 | 3.87 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 188,000.00 |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 713,000.00 |
| Jun 30, 2021 | 244,000.00 |